Watch for Dosing Confusion with Ceftolozane/Tazobactam
Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa).
Ceftolozane/tazobactam is approved for complicated UTIs (cUTIs) and intra-abdominal infections (cIAIs) in adults...and higher doses are still being studied for ventilator-associated pneumonia.
Think of it as primarily covering gram-negative bacteria...including Pseudomonas and ESBL-producing Enterobacteriaceae.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote